As of Jul 06
| -0.0139 / -4.20%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 2.23, with a high estimate of 2.23 and a low estimate of 2.23. The median estimate represents a +603.63% increase from the last price of 0.32.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.